Bayer Deepens Global Collaboration with M2i Group to Expand Access to Sustainable, Pheromone-Based Crop Protection Solutions In a significant move aimed at accelerating the global transition to sustainable agricultural practices, Bayer has announced the expansion of its partnership with French…
Verastem Oncology Publishes Phase 2 RAMP 201 Results: Avutometinib + Defactinib in Recurrent LGSOC Verastem Oncology, focused on therapies for RAS/MAPK pathway-driven cancers, today announced the primary outcomes of the Phase 2 RAMP 201 trial have been published online in JCO.…
Elegen and Nutcracker Therapeutics Launch Cell‑Free Platform for Personalized Cancer RNA Therapies Pilot program introduces the first fully synthetic, cell‑free process to streamline manufacturing of RNA-based personalized cancer therapeutics (PCTs) Elegen, a pioneer in next‑generation DNA manufacturing, and Nutcracker Therapeutics,…
IDT Unveils Advanced Synthetic Biology Center and Gene Fragment Services Faster, Affordable, and Tailored DNA Solutions for Researchers Global genomics leader Integrated DNA Technologies (IDT) has officially launched a state-of-the-art Synthetic Biology Center dedicated to custom gene solutions. This expansion…
Comprehensive Training on GLP Compliance Documentation and Recordkeeping Now Available ResearchAndMarkets.com has recently introduced a new online seminar titled “GLP Laboratory Compliance Documentation and Recordkeeping” designed to equip laboratory professionals with the essential knowledge and skills needed to maintain rigorous…
FeedKind® Pet Protein Proven Safe, Digestible, and Gut-Friendly in Long-Term Study Calysta’s cultured protein shows strong results in peer-reviewed research, paving the way for sustainable innovation in pet food the global leader in large-scale cultured protein production, has announced peer-reviewed…
Broken String Biosciences and BioLizard Join Forces to Build AI Platform for Safer Gene Editing New SafeGuide AI tool aims to reduce trial-and-error in gene editing and lower development costs for next-generation therapies Broken String Biosciences, a pioneer in genomic…
Feinstein Institutes Study Focused Ultrasound to Regulate Blood Sugar After Surgery Researchers and clinicians at Northwell Health’s Feinstein Institutes for Medical Research are breaking new ground in the field of bioelectronic medicine, exploring the use of focused ultrasound (FUS) to…
NTT and Tohoku University Pioneer Quantum Leap with Single-Photon Coherent Ising Machines NTT Research and Tohoku University have jointly achieved a significant scientific milestone, pushing the boundaries of quantum computing by developing a highly energy-efficient and powerful form of Coherent…
Blue Lake and CyanVac Publish Phase 1 Data for Intranasal COVID-19 Vaccine Candidate Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company, and its affiliate CyanVac LLC have announced the publication of the full Phase 1 clinical study data for…
Allurion Submits Final PMA Module to FDA Following Strong AUDACITY Study Results Allurion Technologies, Inc., a global leader in innovative, non-surgical weight loss solutions, announced it has officially submitted the final module of its Pre-Market Approval (PMA) application to the…
Miach Orthopaedics Completes Enrollment in BEAR MOON ACL Study Miach Orthopaedics, Inc., a medical device company revolutionizing anterior cruciate ligament (ACL) treatment, announced that patient enrollment is now complete for its pivotal BEAR MOON study. This major clinical trial compares…